Planned $73.8M Rule 144 ordinary share sale by CRML (NASDAQ: CRML)
Rhea-AI Filing Summary
An affiliate of the issuer has filed a notice under Rule 144 to sell up to 5,000,000 ordinary shares through BMO Capital Markets on NASDAQ. Based on the filing, these shares have an aggregate market value of $73,800,000, and the issuer had 121,464,807 shares outstanding at the time referenced in the table. The shares to be sold were acquired from the issuer on 02/27/2024 in a transaction described as “See Note 2,” in which 5,000,000 shares were obtained and paid for on the same date. The section covering sales in the past three months does not list any prior sales for this seller.
Positive
- None.
Negative
- None.
FAQ
What does the CRML Rule 144 filing disclose?
The filing discloses an intent to sell up to 5,000,000 ordinary shares of the issuer’s stock on NASDAQ under Rule 144, using BMO Capital Markets as broker.
How large is the planned CRML share sale in dollar terms?
The notice reports an aggregate market value of $73,800,000 for the 5,000,000 ordinary shares proposed to be sold.
How many CRML shares are reported as outstanding in this notice?
The table states that 121,464,807 shares of the issuer’s ordinary shares were outstanding as referenced in the filing.
When were the CRML shares proposed for sale originally acquired?
The 5,000,000 ordinary shares to be sold were acquired from the issuer on 02/27/2024, with payment also dated 02/27/2024.
When is the approximate sale date for the CRML shares?
The notice lists an approximate sale date of 01/14/2026 for the proposed sale of the 5,000,000 ordinary shares on NASDAQ.
Which broker is handling the planned CRML Rule 144 sale?
The filing names BMO Capital Markets Corp., located at 151 West 42nd Street, New York, NY 10036, as the broker for the proposed sale.